Extended use of an open-source automated insulin delivery system in children and adults with type 1 diabetes: The 24-week continuation phase following the CREATE randomized controlled trial
Burnside M, Lewis D, Crocket H, et al.
Diabetes Technol Ther. Pub. online 10 Feb 2023.
Leggi


